COMMUNIQUÉS West-GlobeNewswire

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
09/04/2024
- Confirmed objective response rate (ORR) of 15.6% in all patients regardless of PD-L1 or HPV status - Confirmed ORR of 17.4% in subset of patients with PD-L1+ disease - Confirmed ORR of 22.2% in subset of patients with [...]
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
09/04/2024
Major Histocompatibility Complex Class I (MHC-I) negative tumors are refractory to immune-oncology therapies, including resistance to checkpoint blockers, due to the loss of the fundamental recognition of the tumor by [...]
Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024
09/04/2024
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) Website : www.phaxiam.com Date Total of shares [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024
09/04/2024
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024 Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation : [...]
Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting
09/04/2024
Press Release Nicox: 2024 Ordinary and Extraordinary Shareholder Meeting April 9, 2024 – release at 17:30 CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, ALCOX), an international ophthalmology [...]
Nicox : Assemblée Générale Ordinaire et Extraordinaire 2024
09/04/2024
Communiqué de presse Nicox : Assemblée Générale Ordinaire et Extraordinaire 2024 9 avril 2024 – diffusion à 17h30 Sophia Antipolis, France Nicox SA (Euronext Paris : FR0013018124, ALCOX, éligible PEA-PME), société [...]
QIAGEN N.V. to release results for Q1 2024 and hold webcast
09/04/2024
Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024. Press release date / time: Monday, April [...]
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute
09/04/2024
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in [...]
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
09/04/2024
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE, Minn., April 09, 2024 ( [...]
Nelk Boys to Partner With Safety Shot to Bring the Recovery & Wellness Drink to Fans and Followers
09/04/2024
The Nelk Boys, a widely followed YouTube and social media entertainment groups, join Safety Shot as brand ambassadors With over 10 million subscribers across their channels on YouTube, more than 1.6 billion views, and 4 [...]
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
09/04/2024
SOUTH SAN FRANCISCO, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced the acceptance of six [...]
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool
09/04/2024
Launching Co-Pay programs for ZTlido ® and ELYXYB ® for commercially insured patients Multi-State Medicaid Pharmaceutical Purchasing Group added ELYXYB ® to its purchasing pool PALO ALTO, Calif., April 09, 2024 (GLOBE [...]
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
09/04/2024
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth [...]
Verana Health to Reveal Results from Largest Pediatric Intraocular Lens Study, Funded by the FDA, During AAPOS 2024
09/04/2024
Study examined safety and performance of IOL use in nearly 4,000 pediatric patients with cataracts using the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) SAN FRANCISCO, April 09, 2024 [...]
Privia Health to Report First Quarter 2024 Results on Thursday, May 9
09/04/2024
ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on [...]
Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
09/04/2024
IND-enabling studies expected to begin mid-2024 WALTHAM, Mass. and BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision [...]
Signati™ Medical Enrolls First Patient in Groundbreaking Sealed Vasectomy Procedure Trial
09/04/2024
Providence, RI, April 09, 2024 (GLOBE NEWSWIRE) -- Signati™ Medical, a medical device company dedicated to advancing men’s health, today announced the successful enrollment of the first patient in its Investigational [...]
Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® – an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
09/04/2024
PARIS, April 09, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced that today in the Netherlands the first commercial dose of PYLCLARI ® has been sold. PYLCLARI ® (INN: Piflufolastat ( 18 F [...]
Virbac : Declaration of the number of shares and voting rights 03/2024
09/04/2024
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Pages